liarozole has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goss, PE; Hu, H; Qi, S; Strasser-Weippl, K | 1 |
| Fudge, K; Stearns, ME; Wang, M | 1 |
2 other study(ies) available for liarozole and Disease Models, Animal
| Article | Year |
|---|---|
Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Imidazoles; Methylnitrosourea; Ovariectomy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 2007 |
Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Adhesion; Cell Division; Cell Survival; Chemotactic Factors; Collagenases; Disease Models, Animal; Humans; Imidazoles; Isotretinoin; Male; Matrix Metalloproteinase 9; Mice; Mice, SCID; Neoplasm Invasiveness; Neoplasm Transplantation; Prostatic Neoplasms; Tumor Cells, Cultured | 1993 |